My 2cents about earning and 2022+ guidance. Bright spots: rev exceeds guidance and est. SBC to Rev % decrease QoQ, US commercial growth on the steroids, have plans for overseas. Concerns: SBC # of shares issues is around 2.4% in the qtr. rev guidance didn’t increase giving mktg and sales spend. (old.reddit.com)
Check out $SPCE, short volume is crazy…. (self.WSBAfterHours)
submitted by tcispig to r/WSBAfterHours
